Admission Date: [**2185-1-3**]        Discharge Date: [**2185-1-15**]  Date of Birth:  [**2124-7-21**]        Sex:  M  Service:  MED   HISTORY OF PRESENT ILLNESS:  Mr. [**Known lastname **] is a 60-year-old male with metastatic melanoma, admitted to begin cycle 1, week 1 high-dose IL-2 therapy.
His oncologic history began in [**2184-7-27**], when he noted a right groin skin tag which grew quickly over 2 months.
He was evaluated for high-dose IL-2 and passed eligibility testing to begin therapy.
PAST MEDICAL HISTORY:  BPH, status post laparoscopic cholecystectomy in [**2178**], left knee arthroscopic surgery complicated by left DVT, hypertension, sleep apnea, osteoarthritis of the right knee, melanoma as above, benign positional vertigo, history of pseudogout, history of C-7 narrowing with occasional nerve pain.
MEDICATIONS:  Lisinopril 20 mg daily, on hold, Flomax 0.4 mg daily, Proscar 5 mg daily, Naprosyn 500 daily to b.i.d.
HOSPITAL COURSE:  Mr. [**Known lastname **] was admitted and underwent central line placement to begin therapy.
His admission weight was 106.6 kg, and he received interleukin-II 600,000 international units per kilogram, equaling 64 million units IV q.8h.
During this week, he received 10 of 14 doses, with 1 dose held for questionable neurotoxicity and 3 doses held due to development of tachypnea, stridor and respiratory distress, requiring mechanical ventilation.
This event occurred in early morning hours of treatment day #5 and he was transferred emergently to the ICU and intubated, given stridor and tachypnea.
He then became hypotensive, requiring initiation of phenylephrine and Levophed.
At the time of his intubation, his bicarbonate was 15 and he was aggressively treated with bicarbonate repletion.
Other side effects during IL-2 therapy included mild chills; development of an erythematous skin rash; nausea, improved with lorazepam; diarrhea, improved with Lomotil, and fatigue  During this week, he developed acute renal failure with a peak creatinine of 7.3, improved to 1.3 at the time of discharge.
He was anemic with hemoglobin of 7.2, improved to 11.7 after packed red blood cell transfusion.
DISCHARGE DIAGNOSIS:  Metastatic melanoma, status post cycle 1, week 1 high-dose IL-2 complicated by respiratory failure and acute renal failure.
DISCHARGE MEDICATIONS:  Lorazepam 1 mg q.4-6h.
nausea/vomiting, Compazine 10 mg q.6h.
nausea/vomiting, Proscar 5 mg daily, Flagyl 500 mg p.o.
oxycodone 5 to 10 mg q.4h.
pain, Zantac 150 mg p.o.
